Alex Barron

Company: Novartis

Job title: Principal Scientist II, Fibrosis Group

Seminars:

Leveraging Patient Data & Clinical Endpoints for Reverse Translation: Uncovering Efficacious Targets in Fibrotic Diseases 1:30 pm

Examine how large-scale patient data sets can inform early-stage drug discovery and how to leverage these patient data sets to identify potential causative targets Highlighting the connection between functional endpoints and anti-fibrotic effects to understand which functional clinical endpoints are good surrogates for antifibrotic efficacy and targets with a higher probability of being associated with…Read more

day: Day One